Revive Rx
503A Outsourcing Facility — FDA safety data from public records
On This Page
503B outsourcing facility providing sterile injectable compounds, including semaglutide, tirzepatide, and other GLP-1-related formulations for healthcare providers.
Website: revive-rx.com
Data last verified: 2026-04-25
Company Snapshot
Entity Type
503A Outsourcing Facility
FDA Registration
active
Warning Letters
0
Recalls
0
States Licensed
Not listed
Compounding Status
503B
What This Company Profile Actually Tells You
Revive Rx is categorized here as a 503B outsourcing facility or closely related sterile compounding operation. That matters because 503B facilities occupy a different regulatory lane than telehealth brands: they are physical drug establishments with FDA-facing registration obligations and manufacturing-style oversight expectations.
Revive Rx's exact geographic footprint is not summarized on this page, so readers should confirm state availability before assuming access in their market. Readers evaluating a 503B facility should care about sterility controls, batch processes, inspection history, recalls, and whether the facility role being marketed to the public matches the legal operating status reflected in FDA records.
From a search and trust perspective, these pages need to answer a more technical question than a typical company review. Users are not just deciding whether they like the brand. They are trying to understand whether the facility is properly registered, how it is classified, and what public safety signals exist around its operations.
Revive Rx Background
Market Position
Revive Rx is relevant mainly as a facility name inside the GLP-1 supply chain rather than as a patient-facing acquisition brand.
Business Model
Its role is operational and facility-based, so readers should evaluate it using the logic of registration status, facility classification, and fulfillment function rather than consumer-brand marketing.
Pharmacy And Supply Notes
When Revive Rx is named as the dispensing or outsourcing partner, that should prompt questions about documentation, shipping, batch traceability, and the exact product route being used.
Consumer Risk Notes
Backend facility names can feel reassuring once identified, but patients still need a clear explanation of how the facility connects to the prescribing entity and where accountability sits if problems emerge.
Key Facts
Revive Rx matters as a supply-chain name, not primarily as a consumer brand.
Its active registration gives readers a facility record they can verify.
Patients should still ask how Revive Rx fits into the full clinical and fulfillment workflow.
Risk Summary
No FDA warning letters are currently shown in this profile.
No recall events are currently shown in the FDA enforcement data surfaced here.
FDA registration status is shown as active.
Compounding status is listed as 503B.
Regulatory And Compliance Analysis
Registration Context
Revive Rx shows an active FDA registration record in the establishment database. That is a useful signal for facility verification, but it should still be read as registration data rather than a product approval or quality guarantee.
Warning Letter Readout
We did not find FDA warning letters for Revive Rx in this profile. That is better than the alternative, but it is not a blanket endorsement. A clean warning-letter record only tells you that this page is not currently surfacing a published FDA warning letter tied to the entity.
Recall Readout
No recall events are shown for Revive Rx here. For consumers, that lowers one category of concern, but it still does not replace verification of sourcing, labeling, temperature handling, and pharmacy quality controls.
Adverse Event Context
This profile does not currently show a meaningful adverse-event dataset for Revive Rx. In practice, that usually means readers should lean more heavily on registration, recalls, warning letters, and pharmacy-partner transparency when evaluating risk.
FDA Registration
- Status
- FDA Registered
- FEI Number
- 3015442198
- Facility Type
- 503B Outsourcing Facility
- Last Verified
- 2026-04-10
FDA Warning Letters (0)
No FDA warning letters are currently shown for Revive Rx in this profile. That is helpful context, but users should still verify current marketing claims, pharmacy sourcing, and how the company describes compounded medications.
Recall History (0)
No recalls are currently displayed for Revive Rx in the openFDA enforcement data surfaced on this page. That lowers one obvious risk signal, but it should not be treated as proof that all products, batches, or fulfillment practices are problem-free.
Source: openFDA Drug Enforcement API
Adverse Event Reports
This profile does not currently show a meaningful adverse-event summary for Revive Rx. When that dataset is absent, readers should lean more on the documented public record around registration, recalls, warning letters, and pharmacy-partner transparency.
Source: FDA Adverse Event Reporting System (FAERS). Adverse event reports do not establish causation.
Questions Patients Should Ask Before Using Revive Rx
Can Revive Rx confirm the exact facility name, operating status, and whether the prescription will be filled under a 503A or 503B framework?
What does Revive Rx tell patients about compounded versus FDA-approved products, and does that language avoid implying equivalence or approval where it does not exist?
How does Revive Rx handle dose escalations, refill delays, refunds, cancellations, and temperature-sensitive shipping problems?
If a patient has a side effect or receives a product-quality concern, what is the human escalation path and how quickly does Revive Rx respond?
Can Revive Rx provide lot-level documentation, pharmacy details, and a clear explanation of what safety checks happen before medication is dispensed?
Similar Companies
These related profiles are useful for searchers comparing Revive Rx against adjacent providers or pharmacies. Reading similar pages side by side usually reveals whether a concern is unique to one company or common across this category.
How To Use This Profile
This profile organizes public-source safety signals for Revive Rx, including FDA registration status, warning letters, recalls, and any adverse event summary data available in the dataset.
A company can appear relatively clean here and still deserve more diligence, because absence of a warning letter or recall is not the same as proof of quality.
For 503a outsourcing facility pages especially, readers should distinguish between the consumer-facing brand and the pharmacy or facility that actually handles medication production or dispensing.
Looking for a Verified GLP-1 Provider?
FormBlends partners with licensed 503A compounding pharmacies. Every compound is third-party tested with certificates of analysis.
Learn MoreDisclaimer: This page aggregates publicly available data from the FDA, state pharmacy boards, and other government sources. It is provided for informational purposes only and does not constitute medical or legal advice. FDA registration does not imply FDA approval or endorsement. The absence of warning letters or recalls does not guarantee safety or quality. Always consult your healthcare provider before making decisions about medications. Data may not reflect the most current status. Last updated: 2026-04-25.
Safety Guides
503A vs 503B pharmacies
Understanding the FDA oversight difference.
How to read a Certificate of Analysis
What every CoA should include and red flags to watch for.
What FDA registration actually means
Registration vs approval: the distinction most people miss.
Choosing a compounding pharmacy
What to verify before you fill your first prescription.
GLP-1 Safety Alerts
Get notified when the FDA issues warning letters, recalls, or regulatory updates affecting GLP-1 medications and compounding pharmacies.
Free. No spam. Unsubscribe anytime.
Frequently Asked Questions
Is Revive Rx FDA registered?
Revive Rx is currently registered with the FDA. Registration status was last verified on 2026-04-10. Note that FDA registration does not imply FDA approval or endorsement.
Has Revive Rx received any FDA warning letters?
We have not found any FDA warning letters issued to Revive Rx in our records. This page is updated regularly as new FDA data becomes available.
Does Revive Rx have any recalls?
We have not found any recalls associated with Revive Rx in the openFDA enforcement database.
Is Revive Rx a telehealth company or a pharmacy?
Revive Rx is categorized in this profile as a 503a outsourcing facility. That distinction matters because a telehealth brand, a 503A pharmacy, and a 503B outsourcing facility operate under different regulatory expectations.
Does a clean profile mean Revive Rx is definitely safe?
No. A clean profile means we are not currently surfacing certain FDA signals like warning letters or recalls for Revive Rx. It does not guarantee product quality, customer-service quality, or future regulatory compliance.
What should patients verify before using Revive Rx?
Patients should verify who is prescribing, which pharmacy or outsourcing facility is actually fulfilling the medication, what the company says about compounded versus FDA-approved products, and how billing, cancellations, and side-effect escalation are handled.